Page last updated: 2024-08-23

zidovudine and Clerambault Syndrome

zidovudine has been researched along with Clerambault Syndrome in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baijnath, S; Govender, T; Kruger, HG; Mdanda, S; Naicker, T; Ntshangase, S; Singh, SD1
Calkins, MJ; Chen, PC; Hsieh, HC; Hung, KM1
Evans, DL; Perkins, D1
Perry, SW1
Atkinson, H; Grant, I; Ostrow, D1
Marotta, RF; Perry, S1

Reviews

3 review(s) available for zidovudine and Clerambault Syndrome

ArticleYear
Organic mental disorders caused by HIV: update on early diagnosis and treatment.
    The American journal of psychiatry, 1990, Volume: 147, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; AIDS Dementia Complex; Child; Diagnosis, Differential; HIV-1; Humans; Male; Meningoencephalitis; Neurocognitive Disorders; Neuropsychological Tests; Psychiatric Status Rating Scales; Zidovudine

1990
Assessment and management of the AIDS patient with neuropsychiatric disturbances.
    The Journal of clinical psychiatry, 1988, Volume: 49 Suppl

    Topics: Acquired Immunodeficiency Syndrome; Anxiety; Humans; Male; Neurocognitive Disorders; Social Support; Thymidine; Zidovudine

1988
AIDS dementia: a review of the literature.
    Alzheimer disease and associated disorders, 1987, Volume: 1, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Brain; Counseling; Dementia; Humans; Nervous System Diseases; Neurocognitive Disorders; Social Support; Thymidine; Zidovudine

1987

Other Studies

3 other study(ies) available for zidovudine and Clerambault Syndrome

ArticleYear
Zidovudine and Lamivudine as Potential Agents to Combat HIV-Associated Neurocognitive Disorder.
    Assay and drug development technologies, 2019, Volume: 17, Issue:7

    Topics: Animals; Anti-HIV Agents; Chromatography, Liquid; Female; HIV Infections; Injections, Intraperitoneal; Lamivudine; Neurocognitive Disorders; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Tissue Distribution; Zidovudine

2019
Mitochondrial defects arise from nucleoside/nucleotide reverse transcriptase inhibitors in neurons: Potential contribution to HIV-associated neurocognitive disorders.
    Biochimica et biophysica acta. Molecular basis of disease, 2017, Volume: 1863, Issue:2

    Topics: Animals; Cells, Cultured; DNA, Mitochondrial; HIV Infections; Mice, Inbred C57BL; Mitochondria; Neurocognitive Disorders; Neurons; Reverse Transcriptase Inhibitors; Zidovudine

2017
HIV-related major depression: response to zidovudine treatment.
    Psychosomatics, 1991,Fall, Volume: 32, Issue:4

    Topics: Adult; AIDS Dementia Complex; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Neurocognitive Disorders; Zidovudine

1991